RPT1G
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RPT1G, covering 2025-09-02 to 2026-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes [Phase 1]